Literature DB >> 6157802

Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.

E Bartoccioni, F Scuderi, C Scoppetta, A Evoli, P Tonali, L Guidi, C Bartoloni, T Terranova.   

Abstract

The antiacetylcholine receptor antibody was titered in the serum of 63 patients with myasthenia gravis (MG) and 20 control healthy subjects. The titer was significantly high in 92% of MG patients in contrast with none of the controls and no correlation was found with the thymus pathology and the severity of the disease. The titer decreased after thymectomy almost steadily with the improvement of the myasthenic signs. The role of the antibody in the pathogenesis of the disease is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157802     DOI: 10.1007/BF00313202

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations.

Authors:  G Genkins; A E Papatestas; S H Horowitz; P Kornfield
Journal:  Am J Med       Date:  1975-04       Impact factor: 4.965

2.  Acetylcholine receptor antibodies in myasthenia gravis.

Authors:  S H Appel; R R Almon; N Levy
Journal:  N Engl J Med       Date:  1975-10-09       Impact factor: 91.245

3.  A radioimmunoassay for the quantitative evaluation of anti-human acetylcholine receptor antibodies in myasthenia gravis.

Authors:  V M Monnier; B W Fulpius
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

4.  Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.

Authors:  D M Fambrough; D B Drachman; S Satyamurti
Journal:  Science       Date:  1973-10-19       Impact factor: 47.728

5.  Treatment of myasthenia gravis. Report on 139 patients.

Authors:  C Scoppetta; P Tonali; A Evoli; P David; F Crucitti; M L Vaccario
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

6.  Subpopulations of T lymphocytes in myasthenia gravis patients.

Authors:  M Piantelli; L Lauriola; A Carbone; A Evoli; P Tonali; P Musiani
Journal:  Clin Exp Immunol       Date:  1979-04       Impact factor: 4.330

7.  Acetylcholine receptor antibody in myasthenia gravis: purification and characterization.

Authors:  A K Lefvert; K Bergström
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  [Demonstration of acetylcholine receptor antibodies in the serum of myasthenia gravis patients applying affinity chromatographically purified human acetylcholine receptor preparations (author's transl)].

Authors:  I Kalies; J R Kalden; F Heinz; R W Janzen; L Lachenmayer
Journal:  Klin Wochenschr       Date:  1979-09-03

9.  An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis.

Authors:  J Lindstrom
Journal:  Clin Immunol Immunopathol       Date:  1977-01

10.  Ultrastructural localization of the acetylcholine receptor in myasthenia gravis and in its experimental autoimmune model.

Authors:  A G Engel; J M Lindstrom; E H Lambert; V A Lennon
Journal:  Neurology       Date:  1977-04       Impact factor: 9.910

View more
  9 in total

1.  Early-onset myasthenia gravis: clinical characteristics and response to therapy.

Authors:  A P Batocchi; A Evoli; M T Palmisani; M Lo Monaco; M Bartoccioni; P Tonali
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

2.  Circulating CD4+CD8+ cells in myasthenia gravis: supplementary immunological parameter for long-term prognosis.

Authors:  M Matsui; H Fukuyama; I Akiguchi; M Kameyama
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

3.  Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age?

Authors:  Gabriele Monte; Gregorio Spagni; Valentina Damato; Raffaele Iorio; Mariapaola Marino; Amelia Evoli
Journal:  J Neurol       Date:  2021-01-02       Impact factor: 4.849

4.  When is there a full recovery for a myasthenia gravis patient?

Authors:  C Scoppetta; E Bartoccioni; P David; G Flamini; M Lo Monaco; F Scuderi; P Tonali
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

5.  Circulating immune complexes in myasthenia gravis: a study in relation to thymectomy, clinical severity and thymus histology.

Authors:  C Bartoloni; L Guidi; C Scoppetta; P Tonali; E Bartoccioni; G Flamini; G Gambassi; T Terranova
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-10       Impact factor: 10.154

6.  Familial autoimmune myasthenia gravis with different pathogenetic antibodies.

Authors:  C Provenzano; O Arancio; A Evoli; B Rocca; E Bartoccioni; D de Grandis; P Tonali
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-09       Impact factor: 10.154

7.  Aggressive surgical approach for drug-free remission from myasthenia gravis.

Authors:  J E Fischer; H T Grinvalski; M S Nussbaum; H J Sayers; R E Cole; F J Samaha
Journal:  Ann Surg       Date:  1987-05       Impact factor: 12.969

8.  Clinical implementation of anti-acetylcholine receptor antibodies.

Authors:  F E Somnier
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-05       Impact factor: 10.154

9.  Thymectomy in the treatment of myasthenia gravis: report of 247 patients.

Authors:  A Evoli; A P Batocchi; C Provenzano; E Ricci; P Tonali
Journal:  J Neurol       Date:  1988-05       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.